Independently verified assessment of the performance of the fully personalized iTotal CR system over a 7-year period confirms that it meets the panel’s demanding standards BILLERICA, Mass., Feb. 24, ...
BILLERICA, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that 90% of the patients studied in peer-reviewed clinical research published online in The Journal of ...
BILLERICA, Mass., June 22, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration of the Company’s next generation iTotal ® ...
Matthew Levy, MD, an orthopedic surgeon practicing at Cleveland-based St. Vincent Charity Medical Center, is bringing customized knee implant surgery using iTotal technology from ConforMIS, Cleveland ...
BILLERICA, Mass., Jan. 30, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results